Fast-track drug approval in inflammatory bowel diseases

Fast-track drug designation of safe regimens represents an emerging method of development and approval of new medications targeting debilitating diseases including inflammatory bowel diseases (IBD). The goal of accelerated drug approval pathways is to shorten the time between application and approva...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsanos, Konstantinos H., Koutroumpakis, Efstratios, Giagkou, Eftychia, Malakos, Zikos, Almpani, Eleni, Skamnelos, Alexandros, Christodoulou, Dimitrios K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049549/
https://www.ncbi.nlm.nih.gov/pubmed/27708508
http://dx.doi.org/10.20524/aog.2016.0051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049549/
https://www.ncbi.nlm.nih.gov/pubmed/27708508
http://dx.doi.org/10.20524/aog.2016.0051

Ejemplares similares